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Introduction. Helical Tomotherapy (HT) is a modality for delivering intensity modulated radiation therapy (IMRT) treatments
using a rotating linear accelerator mounted on a continuously moving slip ring gantry in synchrony with the couch motion.
HT allows performing stereotactic radiotherapy treatments without ﬁducial markers due to its 3D imaged guided system. Lung
SRBT treatments has been selected as a routine treatment in our facility. Effects of respiratory motion are reduced using an
abdominal compression paddle to restrict tumormotion and normal tissue irradiation.Moreover, HT achieves very homogeneous
dose distributions, leading to local tumor control and survival results comparable to surgery. These IMRT treatments require
patient-speciﬁc veriﬁcation previous to the irradiation, as routine in other IMRT modalities.
Purpose. The aim of this work is to describe the quality assurance (QA) protocol for the veriﬁcation of lung SBRT treatments
performed on HT.
Materials and methods. Prescription doses to PTV were between 45 and 60Gy on 3 fractions. Treatment plans were recalculated
using a solid water cylindrical phantom (Tomophantom) that allows simultaneous measurements with Exradin A1SL cylindrical
ionization chamber (i.c.) in 29 different positions as well as radiochromic EBT2 ﬁlm irradiation, usually located in a coronal plane.
Dose measurements were compared to values from the HT treatment planning system (TPS). Film analysis was performed with
OmniProm I’mRT software and gamma pass rate was evaluated.
Results. Dose differences between TPS calculations and i.c. measurements were mostly within +3%, with −0.7% mean value,
ranged from −3% to 2%. Gamma analysis evaluation showed an agreement superior to 97% (95-100) for 3%,3mm criterium.
Conclusions. The QA protocol proved to be an effective method for veriﬁcation of lung SBRT treatments. Results showed good
agreement between calculated dose from TPS and measurements with i.c. and ﬁlm.
http://dx.doi.org/10.1016/j.rpor.2013.03.625
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Objective. To show the procedure we apply for our radiotheraphy treatments.
Material and methods. Linear accelerator ARTISTE SIEMENS. We check during the ﬁrst three days the patient position relative to
the treatment beams. We have determined by means of portal image or cone bean. We collect the movement X, Y, Z and the
absolute vertical position of the couch in a database. We calculate on the fourth day the average of the three days and modify the
initial SETUP. If with this corrected SETUP on the fourth day, no correction is necessary, we apply it for the rest of the treatment
and do weekly checks. If on the fourth day, a correction is required, we repeat on the ﬁfth and sixth day and on the seventh day
we calculate the average and apply. If the application of the average does not need any correction we apply this average for the
rest of the treatment. We have a weekly control check. If the average needs correction, we consider the patient unstable, and we
will do portal image or cone bean, daily.
Results. 1. ORTHOGONAL PORTAL IMAGE, 3 initials + week: Breast, palliative: – 10 sessions 2. CONE BEAN 3 initials + week: Lung,
otolaryngologist, Rectum, Cerebral, Lymph, Stomach, Pancreas, Esophagus 3. ORTHOGONAL PORTAL IMAGE + 1 week: Cranial
irradiation 4. DAILY PORTAL IMAGE: Palliative care: 5 sessions 5. DAILY CONE BEAN: Prostate.
Conclusions. We collect in a database the necessary information that we use for a good daily positioning, minimizing an error
that we could apply to the positioning of a patient every day.
http://dx.doi.org/10.1016/j.rpor.2013.03.626
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Introduction. The arrival of Rapid Arc (RA) technique has gradually replaced IMRT treatments at our unit.
Objectives. To evaluate the dosimetric outcomes of prostate treatment plans and the possibility of reduction of peripheral dose
and treatment delivery time.
Material. Ten cases are planned to target a prescription dose of 78Gy of mean dose in PTV and D95>95%, in 2Gy/fraction, for
a 5 ﬁeld IMRT (G265◦, G312◦, G0◦, G47◦ and G95◦) and two full Rapid arcs, delivered with Varian Clinac iX, for a beam energy
of 6MV and a maximum dose rate of 600MU/min. The CBCT performance allows the acquisition of KV images for positioning
and evaluation of changes in bladder and rectum size. Treatment planning system used is Varian Eclipse 8.9.17 with inverse
